Virtu Financial LLC Cti Biopharma Corp Transaction History

Virtu Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$3.55 - $6.27 $347,207 - $613,237	97,805 New	97,805 $584,000
Q1 2021 May 19, 2021	SELL	$2.68 - $3.8 $49,271 - $69,863	-18,385 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$2.48 - $3.8 $45,594 - $69,863	18,385 New	18,385 $59,000
Q4 2019 Feb 04, 2020	SELL	$0.72 - $1.64 $11,320 - $25,785	-15,723 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$0.64 - $0.92 $3,321 - $4,774	5,190 Added 49.27%	15,723 $13,000
Q2 2019 Aug 13, 2019	BUY	$0.8 - $1.03 $8,426 - $10,848	10,533 New	10,533 $9,000
Q1 2019 Apr 12, 2019	SELL	$0.9 - $1.37 $22,708 - $34,567	-25,232 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$0.73 - $2.19 $6,875 - $20,627	9,419 Added 59.56%	25,232 $19,000
Q3 2018 Nov 13, 2018	BUY	$1.72 - $5.24 $27,198 - $82,860	15,813 New	15,813 $34,000
Q2 2018 Jul 30, 2018	SELL	$3.81 - $5.26 $125,649 - $173,469	-32,979 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$3.81 - $5.26 $40,172 - $55,461	-10,544 Reduced 24.23%	32,979 $164,000
Q1 2018 May 14, 2018	BUY	$2.7 - $4.06 $117,512 - $176,703	43,523 New	43,523 $170,000
Q4 2017 Feb 09, 2018	SELL	$2.47 - $3.34 $41,589 - $56,238	-16,838 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$3.12 - $3.65 $52,534 - $61,458	16,838	16,838 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.